Delivering precision healthcare
innovations to transform patient care.
What We Do
At MBM, we are dedicated to becoming a world-class commercialization platform for precision healthcare products and services. In the world of life sciences today, there is no shortage of innovative discoveries. However, a significant gap exists between cutting edge discovery and turning these discoveries into a product that helps patients in need.
MBM’s sole purpose is to identify core technologies that will address unmet medical needs and translating these technologies into products that will help patients in China and around in the world. We are currently focused on novel cancer biomarker discovery and product development using MBMbio’s proprietary AI digital pathology and Red Blood Cell (RBC) liquid biopsy platforms.
We are working to develop the next wave of healthcare innovations.
Who Are We
We are leaders and experts in our field. Say hello to our team.
Latest Blog Posts
News and healthcare tips
MBMbio announced residency at JLABS @ ShanghaiDecember 1, 2021Shanghai China, December 1, 2021 – MBMbio announced today that, effective...
The Often Neglected Red Blood Cell Offers a Breakthrough in Liquid Biopsy Technology for Early Stage Cancer Detection
MBM’s “Colorectal Cancer Recurrence Risk Assessment Marker” announced at the National Colorectal Surgery Symposium
MBM recognized as a Top 30 enterprise in the 2020 National Innovation & Entrepreneurship Competition
The revolution requires the right people.